Application of Quality by Design Approach to the Pharmaceutical Development of Anticancer Crude Extracts of Crocus sativus Perianth

被引:4
|
作者
Mykhailenko, Olha [1 ]
Ivanauskas, Liudas [2 ]
Bezruk, Ivan [1 ]
Petrikaite, Vilma [3 ,4 ]
Georgiyants, Victoriya [1 ]
机构
[1] Natl Univ Pharm, Dept Pharmaceut Chem, UA-61168 Kharkiv, Ukraine
[2] Lithuanian Univ Hlth Sci, Dept Analyt & Toxicol Chem, LT-44307 Kaunas, Lithuania
[3] Lithuanian Univ Hlth Sci, Inst Cardiol, Lab Drug Targets Histopathol, LT-50162 Kaunas, Lithuania
[4] Vilnius Univ, Life Sci Ctr, Inst Biotechnol, LT-10257 Vilnius, Lithuania
关键词
Quality by Design; risk assessment; design of experiments; Herbal Chemical Marker Ranking System; failure mode and effect analysis; saffron; anticancer herbal drugs; BREAST-CANCER CELLS; EXERTS ANTITUMOR-ACTIVITY; IN-VITRO; CYCLE ARREST; LUNG CARCINOGENESIS; DOWN-REGULATION; FERULIC ACID; L; CONSTITUENTS; MECHANISM;
D O I
10.3390/scipharm90010019
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The application of the Quality by Design (QbD) concept to extracts obtained from Crocus sativus perianth with potential anticancer activity will ensure the safety, efficiency, and quality control of the entire technological process, as well as determine the critical factors affecting the quality of extracts. Potentially critical points of the production of the plant extracts, including the cultivation and processing of the plant materials, the extraction process, and the choice of solvents, were identified using the Ishikawa diagram and FMEA risk assessment methods as well as the corrective actions proposed. The Herbal Chemical Marker Ranking System (HerbMars) approach was used to justify the Q-markers choice of Crocus, which takes into account bioavailability, pharmacological activity, and the presence of the selected standard. An experimental design (DoE) was used to assess the influence of potentially critical factors on the efficiency of the compound extraction from raw materials with water or ethanol. The presence of 16 compounds in Crocus perianth was determined by HPLC and their quantitative assessment was established. Selected compounds (ferulic acid, mangiferin, crocin, rutin, isoquercitrin) can be used for the quality control of Crocus perianth. In addition, the stigmas from the Volyn region met the requirements of ISO 3632 for saffron as a spice (category I). The cytotoxic activity against melanoma (IGR39) and triple-negative breast cancer (MDA-MB-231) cell lines of the hydroethanolic extract of C. sativus perianth was significantly more pronounced than the water extract, probably due to the chemical composition of the constituent components. The results show that the QbD approach is a powerful tool for process development for the production of quality herbal drugs.
引用
收藏
页数:23
相关论文
共 50 条
  • [41] Application of quality by design in the current drug development
    Lan Zhang
    Shirui Mao
    AsianJournalofPharmaceuticalSciences, 2017, 12 (01) : 1 - 8
  • [42] ASSURING QUALITY IN DEVELOPMENT AND DESIGN - AN ANTITHETICAL APPROACH
    MULLER, FW
    QUALITY PROGRESS, 1984, 17 (09) : 18 - 21
  • [44] Development of Atovaquone Nanosuspension Quality by Design:Approach
    Kakade, Pratik
    Gite, Sandip
    Patravale, Vandana
    CURRENT DRUG DELIVERY, 2020, 17 (02) : 112 - 125
  • [45] Quality by Design Approach of a Pharmaceutical Gel Manufacturing Process, Part 1: Determination of the Design Space
    Rosas, Juan G.
    Blanco, Marcel
    Gonzalez, Josep M.
    Alcala, Manel
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 100 (10) : 4432 - 4441
  • [46] Using an innovative Quality-by-Design approach for development of a stability indicating UHPLC method for ebastine in the API and pharmaceutical formulations
    Schmidt, Alexander H.
    Molnar, Imre
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2013, 78-79 : 65 - 74
  • [47] An Application of Quality by Design and Analytical Greenness Assessment Approach for the Development of Erlotinib Stability Indicating Method
    Satyam Gundecha
    Mital Patel
    Y. C. Mayur
    Chromatographia, 2022, 85 : 575 - 588
  • [48] An Application of Quality by Design and Analytical Greenness Assessment Approach for the Development of Erlotinib Stability Indicating Method
    Gundecha, Satyam
    Patel, Mital
    Mayur, Y. C.
    CHROMATOGRAPHIA, 2022, 85 (07) : 575 - 588
  • [49] QUALITY BY DESIGN APPROACH FOR THE DEVELOPMENT AND VALIDATION OF SAXAGLIPTIN BY RP-HPLC WITH APPLICATION TO FORMULATED FORMS
    Daswadkar, Shubhangi C.
    Roy, Madhumita A.
    Walode, Sanjay G.
    Kumar, Mahendra C. B.
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2016, 7 (04): : 1670 - 1677
  • [50] Implementing Quality by Design in Pharmaceutical Salt Selection: A Modeling Approach to Understanding Disproportionation
    Jeremy M. Merritt
    Shekhar K. Viswanath
    Gregory A. Stephenson
    Pharmaceutical Research, 2013, 30 : 203 - 217